From: Dynamic simulations on the mitochondrial fatty acid Beta-oxidation network
Acylcarnitines [μmol/l] | C4 | C6 | C8 | C10 | C12 | C14 | C16 | C18 | ||
---|---|---|---|---|---|---|---|---|---|---|
Middle Europe | healthy controls (n = 590.216) | median | 0.38 | 0.12 | 0.10 | 0.09 | 0.13 | 0.21 | 4.37 | 0.97 |
IQR | 0.27 | 0.14 | 0.07 | 0.09 | 0.09 | 0.13 | 2.18 | 0.52 | ||
MCAD deficiency (n = 63) | median | 0.40 | 1.31 | 5.14 | 0.59 | 0.11 | 0.19 | 3.47 | 0.80 | |
IQR | 0.23 | 1.27 | 8.78 | 0.64 | 0.10 | 0.12 | 1.59 | 0.46 | ||
VLCAD deficiency (n = 5) | median | 0.28 | 0.11 | 0.12 | 0.15 | 0.47 | 0.85 | 3.15 | 1.38 | |
IQR | 0.11 | 0.07 | 0.08 | 0.13 | 0.19 | 0.45 | 1.04 | 1.44 | ||
South Australia | MCAD deficiency (n = 13) | median | 0.32 | 0.97 | 7.23 | 1.10 | 0.25 | 0.32 | 3.49 | 2.69 |
IQR | 0.07 | 0.95 | 7.27 | 0.39 | 0.09 | 0.13 | 1.80 | 1.18 | ||
VLCAD deficiency (n = 3) | median | 0.40 | 0.16 | 0.15 | 0.34 | 1.19 | 2.41 | 4.99 | 3.11 | |
IQR | 0.27 | 0.08 | 0.10 | 0.21 | 0.42 | 2.71 | 3.22 | 5.43 |